Compare SCNX & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCNX | COSM |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | United States | United States |
| Employees | 19 | N/A |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0M | 15.8M |
| IPO Year | N/A | 2009 |
| Metric | SCNX | COSM |
|---|---|---|
| Price | $0.36 | $0.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | 314.3K | ★ 1.2M |
| Earning Date | 05-13-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,271,815.00 |
| Revenue This Year | $1,097.38 | $54.08 |
| Revenue Next Year | $239.80 | $32.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.24 | $0.25 |
| 52 Week High | $2.60 | $1.32 |
| Indicator | SCNX | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 38.07 |
| Support Level | $0.24 | $0.25 |
| Resistance Level | $0.48 | $0.41 |
| Average True Range (ATR) | 0.03 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 1.54 | 4.25 |
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.